Dataset Information

Teaching hospital alternatives for Veterans Health Administration facilities: A Google Maps proximity study.

ABSTRACT: The United States Veterans Health Administration (VHA) serves more than 9 million enrolled Veterans each year. Although most of the care that the VHA sponsors is delivered within its own facilities, there has been a call for "privatizing" some or all of these services. Under such an arrangement, the Department of Veterans Affairs would pay non-VHA providers to deliver care in facilities open to the general public. Privatization is hotly contested on political grounds and is not resolved. Yet the question whether the VHA should be privatized cannot be resolved without first establishing that this policy change is even feasible. One potential obstacle to privatization would be the lack of nearby alternative facilities to deliver care. To assess for the presence of this impediment, we used Google Maps to measure the travel time between 167 VA hospitals and the teaching hospital nearest to each of them. We determined that the mean travel time between VA hospitals and their nearest teaching hospital was approximately 18 minutes with a median of 10 minutes. All but nine VA facilities were within two hours' travel, and these nine within ten minutes' travel to a tertiary care, nonteaching hospital. These data do not definitively resolve the privatization debate, of course, but do refute the assertion that inpatient VA services cannot be privatized because replacement hospitals are too far away. As shown, that is simply not the case.

SUBMITTER: Bernstein J

PROVIDER: S-EPMC6033449 | biostudies-other | 2018

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Teaching hospital alternatives for Veterans Health Administration facilities: A Google Maps proximity study.

Bernstein Joseph J Mead Loren L

PloS one 20180705 7

The United States Veterans Health Administration (VHA) serves more than 9 million enrolled Veterans each year. Although most of the care that the VHA sponsors is delivered within its own facilities, there has been a call for "privatizing" some or all of these services. Under such an arrangement, the Department of Veterans Affairs would pay non-VHA providers to deliver care in facilities open to the general public. Privatization is hotly contested on political grounds and is not resolved. Yet the ...[more]

PMID: 29975748

Similar Datasets

Project description:BACKGROUND:Inappropriate testosterone use and variations in testosterone prescribing patterns exist in the Veterans Health Administration (VHA) despite the presence of clinical guidelines. OBJECTIVE:We examined system and clinician factors that contribute to patterns of potentially inappropriate testosterone prescribing in VHA. DESIGN:Qualitative study using a positive deviance approach to understand practice variation in high- and low-testosterone prescribing sites. PARTICIPANTS:Twenty-two interview participants included primary care and specialty clinicians, key opinion leaders, and pharmacists at 3 high- and 3 low-testosterone prescribing sites. APPROACH:Semi-structured phone interviews were conducted, transcribed, and coded using a priori theoretical constructs and emergent themes. Case studies were developed for each site and a cross-case matrix was created to evaluate variation across high- and low-prescribing sites. KEY RESULTS:We identified four system-level domains related to variation in testosterone prescribing: organizational structures and processes specific to testosterone prescribing, availability of local guidance on testosterone prescribing, well-defined dissemination process for local testosterone polices, and engagement in best practices related to testosterone prescribing. Two clinician-level domains were also identified, specifically, structured initial testosterone prescribing process and specified follow-up testosterone prescribing process. High- and low-testosterone prescribing sites systematically varied in the four system-level domains, while the clinician-level domains looked similar across all sites. The third high-prescribing site was unusual in that it exhibited the four domains similar to the 3 low-prescribing sites at the time of our visit. This site had greatly reduced its prescribing of testosterone in the interim. CONCLUSIONS:Findings suggest that local organizational factors play an important role in influencing prescribing. Sites have the potential to transform their utilization patterns by providing access to specialty care expertise, an electronic health record-based system to facilitate guideline-concordant prescribing, well-defined dissemination processes for information, guidance from multiple sources, and clarity regarding best practices for prescribing.

Project description:ImportanceThere is controversy about the benefit of prostate-specific antigen (PSA) screening. Prostate-specific antigen screening rates have decreased since 2008 in the US, and the incidence of metastatic prostate cancer has increased. However, there is no direct epidemiologic evidence of a correlation between population PSA screening rates and subsequent metastatic prostate cancer rates.ObjectiveTo assess whether facility-level variation in PSA screening rates is associated with subsequent facility-level metastatic prostate cancer incidence.Design, setting, and participantsThis retrospective cohort used data for all men aged 40 years or older with an encounter at 128 facilities in the US Veterans Health Administration (VHA) from January 1, 2005, to December 31, 2019.ExposuresYearly facility-level PSA screening rates, defined as the proportion of men aged 40 years or older with a PSA test in each year, and long-term nonscreening rates, defined as the proportion of men aged 40 years or older without a PSA test in the prior 3 years, from January 1, 2005, to December 31, 2014.Main outcomes and measuresThe main outcomes were facility-level yearly counts of incident metastatic prostate cancer diagnoses and age-adjusted yearly metastatic prostate cancer incidence rates (per 100 000 men) 5 years after each PSA screening exposure year.ResultsThe cohort included 4 678 412 men in 2005 and 5 371 701 men in 2019. Prostate-specific antigen screening rates decreased from 47.2% in 2005 to 37.0% in 2019, and metastatic prostate cancer incidence increased from 5.2 per 100 000 men in 2005 to 7.9 per 100 000 men in 2019. Higher facility-level PSA screening rates were associated with lower metastatic prostate cancer incidence 5 years later (incidence rate ratio [IRR], 0.91 per 10% increase in PSA screening rate; 95% CI, 0.87-0.96; P < .001). Higher long-term nonscreening rates were associated with higher metastatic prostate cancer incidence 5 years later (IRR, 1.11 per 10% increase in long-term nonscreening rate; 95% CI, 1.03-1.19; P = .01).Conclusions and relevanceFrom 2005 to 2019, PSA screening rates decreased in the national VHA system. Facilities with higher PSA screening rates had lower subsequent rates of metastatic prostate cancer. These data may be used to inform shared decision-making about the potential benefits of PSA screening among men who wish to reduce their risk of metastatic prostate cancer.

Dataset Information

Teaching hospital alternatives for Veterans Health Administration facilities: A Google Maps proximity study.

Publications

Teaching hospital alternatives for Veterans Health Administration facilities: A Google Maps proximity study.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets